Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 190

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 6
Chunk 190
---
 is or has been within the last three
years, an executive officer of an entity if any of the issuer’s current executive officers serves or served at that same time on
the entity’s compensation committee; and (f) an individual who received, or whose immediate family member who is employed as an
executive officer of the issuer received, more than $75,000 in direct compensation from the issuer during any 12 month period within the
last three years.

Our Board has undertaken a review of the independence
of each director. Based on information provided by each director concerning his or her background, employment and affiliations, our Board
has determined that Yehonatan Shachar, Amitay Weiss, and Oz Adler, representing three of the four members of our Board, are “independent”
as that term is defined under the Nasdaq Rules and NI 58-101. In making this determination, our Board considered the current and prior
relationships that each non-employee director has with our Company and all other facts and circumstances our Board deemed relevant in
determining their independence, including the beneficial ownership of our shares by each non-employee director.

Certain members of our Board are also members of
the boards of other public companies. Our Board has not adopted a director interlock policy, but is keeping informed of other public directorships
held by its members.

Mandate of the Board of Directors

Our Board is responsible for supervising the management
of our business and affairs, including providing guidance and strategic oversight to management. Our Board will adopt a formal mandate
that will include the following:

  appointing our Chief Executive Officer;  

  developing the corporate goals and objectives that our Chief Executive Officer is responsible for meeting and reviewing the performance of our Chief Executive Officer against such corporate goa...  

  taking steps to satisfy itself as to the integrity of our Chief Executive Officer and other executive officers and that our Chief Executive Officer and other executive officers create a culture...  

  reviewing and approving our code of conduct and reviewing and monitoring compliance with the code of conduct and our enterprise risk management processes;  

  reviewing and approving management’s strategic and business plans and our financial objectives, plans and actions, including significant capital allocations and expenditures; and  

  reviewing and approving material transactions not in the ordinary course of business.  

Meetings of Independent Directors

Our Board will hold regularly-scheduled quarterly
meetings as well as ad hocmeetings from time to time. The independent members of our Board will also meet, from time